Ad is loading...
ABOS
Price
$2.33
Change
+$0.02 (+0.87%)
Updated
Nov 22, 03:02 PM (EDT)
129 days until earnings call
TNYA
Price
$2.35
Change
+$0.19 (+8.80%)
Updated
Nov 22, 03:39 PM (EDT)
123 days until earnings call
Ad is loading...

ABOS vs TNYA

Header iconABOS vs TNYA Comparison
Open Charts ABOS vs TNYABanner chart's image
Acumen Pharmaceuticals
Price$2.33
Change+$0.02 (+0.87%)
Volume$500
CapitalizationN/A
Tenaya Therapeutics
Price$2.35
Change+$0.19 (+8.80%)
Volume$618
CapitalizationN/A
ABOS vs TNYA Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABOS vs. TNYA commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and TNYA is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ABOS: $2.31 vs. TNYA: $2.16)
Brand notoriety: ABOS and TNYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 65% vs. TNYA: 109%
Market capitalization -- ABOS: $138.78M vs. TNYA: $171.12M
ABOS [@Biotechnology] is valued at $138.78M. TNYA’s [@Biotechnology] market capitalization is $171.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileTNYA’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • TNYA’s FA Score: 1 green, 4 red.
According to our system of comparison, TNYA is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while TNYA’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • TNYA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TNYA is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -11.49% price change this week, while TNYA (@Biotechnology) price change was +6.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.97%.

Reported Earning Dates

ABOS is expected to report earnings on Mar 31, 2025.

TNYA is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNYA($171M) has a higher market cap than ABOS($139M). TNYA YTD gains are higher at: -33.333 vs. ABOS (-39.844). ABOS has higher annual earnings (EBITDA): -77.89M vs. TNYA (-114.18M). ABOS has more cash in the bank: 200M vs. TNYA (79.5M). TNYA has less debt than ABOS: TNYA (14.5M) vs ABOS (28.5M). ABOS (0) and TNYA (0) have equivalent revenues.
ABOSTNYAABOS / TNYA
Capitalization139M171M81%
EBITDA-77.89M-114.18M68%
Gain YTD-39.844-33.333120%
P/E RatioN/AN/A-
Revenue00-
Total Cash200M79.5M252%
Total Debt28.5M14.5M197%
TECHNICAL ANALYSIS
Technical Analysis
ABOSTNYA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCDAX39.290.62
+1.60%
Fidelity Advisor Stock Selector Sm Cp A
PMVAX23.320.35
+1.52%
Putnam Sustainable Future A
HADUX74.730.54
+0.73%
Horizon Equity Premium Income Advisor
CFCYX14.210.08
+0.57%
Columbia Flexible Capital Income Inst3
TQEZX8.97N/A
N/A
AMG TimesSquare Emerging Mkts Sm Cp Z

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with INZY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-2.53%
INZY - ABOS
49%
Loosely correlated
-3.58%
AURA - ABOS
49%
Loosely correlated
+3.20%
BEAM - ABOS
48%
Loosely correlated
-3.72%
GBIO - ABOS
48%
Loosely correlated
-2.22%
ALEC - ABOS
48%
Loosely correlated
+3.44%
More

TNYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with ABOS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
-2.70%
ABOS - TNYA
45%
Loosely correlated
-2.53%
NTLA - TNYA
44%
Loosely correlated
+5.18%
BEAM - TNYA
42%
Loosely correlated
-3.72%
CRSP - TNYA
42%
Loosely correlated
-2.05%
INZY - TNYA
42%
Loosely correlated
-3.58%
More